Our findings of high circulating levels of sTfR1 together with low levels of GPX4 are consistent with the hypothesis that ferroptosis may be over-activated in COPD, similar to what has been reported for ferroptosis associated with diabetic nephropathy [26, 27]. Here, GPX4 is linked to diabetic kidney disease.